Navigation Links
Novel Treatment Found To Prolong Survival Of Liver Cancer Patients

Surgery remains the most effective treatment option for patients with liver cancer. A cloud of confusion however remains regarding the best way to treat a patient who harbors a liver tumor that cannot be removed by surgery. //Infact very little surgical options are currently available for this group of patients.

Thanks to the perseverant work of the researchers who have now suggested a novel plan for combating these tumors using radiotherapy. The radiotherapy is targeted precisely at the tumor and is delivered in combination with chemotherapy approximated to a dose of 400 folds the conventional dose. The radiation oncologists designed a treatment that directly targets the tumor, using conformal radiation techniques that pinpoint precisely where the radiation beams go. This unique approach minimizes the radiation exposure to normal liver tissue.

The study was conducted on nearly 128 patients with either cancer of the bile duct, liver or colon that were regarded as inoperable. The study participants received radiation twice daily for two weeks, along with a continuous infusion of the chemotherapy drug floxuridine. The chemotherapy was administered through a catheter into the artery that supplies the liver. A two-week break was allowed before the same regime was continued for another two weeks.

Liver cancers have limited success with radiotherapy owing to the fact that the liver is extremely sensitive to radiation. In addition, multi-drug resistance is a common problem manifested in a majority of the liver cancers. Therefore has not been regarded as a viable option in the treatment strategy.

The study participants had a projected survival rate of eight or nine months. The treatment was found to prolong the survival rate to as much as 15.8 months in a statistically significant way in comparison to the traditional rates. Patients with liver, bile duct and colon cancer were found to live for an average of 15.2, 13.2 and 17.2 months respectively.

Nearly, one third of the treated patients had severe complications ranging from upper gastrointestinal ulcers or bleeding, liver disease to problems associated with the catheter. Research is also underway to further refine techniques for effective delivery of radiation. It has also been proposed to test liver function as a parallel approach to predict the response of the patients to the combined modality approach.


Related medicine news :

2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel way to fight cancer
6. Novel test for bowel cancer
7. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
8. Novel Therapy for Chronic Problem
9. Blood Sugar Kept In Control By Novel Protein
10. Novel antibiotic dressing developed for improved wound healing
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:

(Date:12/1/2015)... ... December 01, 2015 , ... The workstation boundaries for ... IMAGE Information Systems launches MED-TAB™ -- the world’s first portable DICOM-calibrated medical image ... 29 to December 4, 2015. , MED-TAB is expected to change teleradiology ...
(Date:12/1/2015)... ... , ... The importance of volumetric breast density assessment for ... abstracts accepted for presentation here, at the 101st Annual Radiology Society of North ... of Volpara Solutions’ quantitative breast imaging software tools for providing breast imaging and ...
(Date:12/1/2015)... ... December 01, 2015 , ... For ... That is why Hollister Incorporated has launched the VaPro Plus Pocket™ touch free ... in the VaPro touch free catheter portfolio,” said Michael Gresavage, Vice President North ...
(Date:12/1/2015)... ... December 01, 2015 , ... SAN FRANCISCO, Calif. (December 1, ... organization has awarded Education and Developmental Therapies (EDT), an Applied Behavior Analysis (ABA) ... exceptional special needs providers that excel in synthesizing the areas of clinical quality, ...
(Date:12/1/2015)... ... December 01, 2015 , ... McLean, ... been awarded a fixed price per sprint agile development contract to support the ... million over five years, provides software engineering, infrastructure, as well as operations and ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... During the recent 2015 Transcatheter Cardiovascular ... CA , Medinol Ltd. continued to introduce ... a satellite symposium, "The BioNIR eDES: The Role ... a renowned physician panel discussed the key attributes ... Stent System and the Medinol eDES Coronary Stent ...
(Date:12/1/2015)... YORK , Dec. 1, 2015 Relmada Therapeutics, ... the treatment of chronic pain, announced today that the company ... will be held December 1-3 at the Luxe Sunset Boulevard ... Sergio Traversa , CEO of Relmada Therapeutics, will present on ... Eastern Time). . Please register at least ...
(Date:12/1/2015)... Dec. 1, 2015  InCarda Therapeutics, Inc. (InCarda), a ... of therapies for cardiovascular conditions via the inhalation route, ... in Australia . InCarda is planning ... Australia in the first half of ... medical centers in Adelaide and ...
Breaking Medicine Technology: